Physician profile
Ada Kagumba
NPI 1356314728
$2,347.48
in general payments reported to CMS, 2019-2025
29 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $147 · 2021: $617 · 2022: $661 · 2023: $345 · 2024: $239 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $555.88 | 2019-2025 | |
| Myovant Sciences INC. | $251.00 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $172.78 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $138.08 | 2022-2025 | Veozah |
| Therapeuticsmd, INC. | $137.61 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $136.12 | 2021-2025 | |
| Amgen INC. | $128.12 | 2021-2024 | Evenity, Prolia |
| Ethicon US, LLC | $108.71 | 2021-2024 | Stratafix |
| Organon LLC | $100.83 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $93.80 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.55 | 2022-2025 | |
| Hologic Sales and Service, LLC | $69.36 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Medtronic, INC. | $52.35 | 2022 | |
| Merck Sharp & Dohme LLC | $38.21 | 2020-2021 | |
| Pfizer INC. | $30.97 | 2022-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $25.84 | 2021 | |
| Heron Therapeutics, INC. | $25.03 | 2022 | |
| Becton, Dickinson and Company | $21.99 | 2021 | |
| Exeltis, USA INC. | $19.36 | 2023 | Slynd |
| Vertex Pharmaceuticals Incorporated | $18.95 | 2025 | |
| Novo Nordisk INC | $17.44 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.00 | 2023 | Ultomiris |
| Pacira Pharmaceuticals Incorporated | $16.66 | 2023 | Exparel |
| Meditrina | $16.16 | 2024 | |
| Dexcom, INC. | $15.93 | 2024 | Dexcom G6 Transmitter |
| Axonics, INC. | $14.46 | 2022 | |
| Coopersurgical, INC. | $13.09 | 2023 | Summit Doppler |
| Duchesnay USA Incorporated | $13.02 | 2019 | |
| Lsi Solutions INC | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ada Kagumba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.